Montvale Technologies Inc. Stock Analysis IVVI
Ivivi Technologies, Inc. engages in the design, development, and commercialize of proprietary electrotherapeutic technologies for the non-invasive treatment of acute and chronic disorders of soft tissue. The company is headquartered in Northvale, New Jersey and currently employs 15 full-time employees. The company went IPO on 2006-10-19. The firm has focused its research and development activities on targeted pulsed electromagnetic field (tPEMF) technology. The firm is marketing products utilizing its tPEMF technology to various surgery markets for adjunctive use in the treatment of post operative pain and edema in superficial soft tissue. The firm is developing technology for other therapeutic medical markets.
Read More Montvale Technologies Inc (IVVI) Chart
Financial Metrics & Statements of Montvale Technologies Inc (IVVI)
FAQ's for Montvale Technologies Inc (IVVI)
- According to Musaffa’s Shariah screening methodology, Montvale Technologies Inc (IVVI) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.